je.st
news
Home
› CEO Frazier: Merck is eager for deals, sees strong prospects for drugs for cancer, hepatitis C
CEO Frazier: Merck is eager for deals, sees strong prospects for drugs for cancer, hepatitis C
2016-01-05 22:22:53| Biotech - Topix.net
Merck's chief executive says the drugmaker is "raring to go" on deals this year, particularly for small and midsize acquisitions of companies or their experimental drugs. CEO Kenneth Frazier, speaking Tuesday at a Goldman Sachs conference of CEOs of health care companies in Boston, also said he expects more approvals and growing sales from new cancer drug Keytruda.
Tags: strong
deals
cancer
drugs
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||